SBRT Treatment Planning With VMAT Versus IMRT: Impact of Duodenal Sparing on Tumor Coverage in Patients With Locally Advanced Pancreatic Adenocarcinoma

被引:0
|
作者
Kumar, R. [1 ]
Wild, A. T. [1 ]
Ziegler, M. A. [1 ]
Kang, J. [1 ]
Smith, K. S. [1 ]
Tryggestad, E. [1 ]
Ford, E. [1 ]
Wong, J. [1 ]
Hooker, T. [1 ]
Herman, J. [1 ]
机构
[1] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
关键词
D O I
10.1016/j.ijrobp.2012.07.2097
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S783 / S784
页数:2
相关论文
共 50 条
  • [42] Prognostic value of gross tumor volume delineated by FDG-PET-CT based radiotherapy treatment planning in patients with locally advanced pancreatic cancer treated with chemoradiotherapy
    Cem Parlak
    Erkan Topkan
    Cem Onal
    Mehmet Reyhan
    Ugur Selek
    Radiation Oncology, 7
  • [43] Prognostic value of gross tumor volume delineated by FDG-PET-CT based radiotherapy treatment planning in patients with locally advanced pancreatic cancer treated with chemoradiotherapy
    Parlak, Cem
    Topkan, Erkan
    Onal, Cem
    Reyhan, Mehmet
    Selek, Ugur
    RADIATION ONCOLOGY, 2012, 7
  • [44] CEA and CA-19.9 Serum Tumor Markers as Prognostic Factors in Patients with Locally Advanced (Unresectable) or Metastatic Pancreatic Adenocarcinoma: A Retrospective Analysis
    Tsavaris, N.
    Kosmas, C.
    Papadoniou, N.
    Kopteridis, P.
    Tsigritis, K.
    Dokou, A.
    Sarantonis, J.
    Skopelitis, H.
    Tzivras, M.
    Gennatas, K.
    Polyzos, A.
    Papastratis, G.
    Karatzas, G.
    Papalambros, A.
    JOURNAL OF CHEMOTHERAPY, 2009, 21 (06) : 673 - 680
  • [45] Evaluation of the prognostic impact of circulating free tumor DNA (cftDNA) dynamics in borderline resectable (BR) or locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC)
    Grelli, G.
    Crucitta, S.
    Genovesi, V.
    Bartalini, L.
    Salani, F.
    Massa, V.
    Fornaro, L.
    Mangogna, F.
    Cesario, S.
    Bernardini, L.
    Caccese, M.
    Graziani, J.
    Berra, D.
    Lencioni, M.
    Masi, G.
    Danesi, R.
    Vasile, E.
    Del Re, M.
    Vivaldi, C.
    ANNALS OF ONCOLOGY, 2024, 35 : S154 - S154
  • [46] Pre-SBRT Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients With Locally Advanced Pancreatic Cancer Receiving Stereotactic Body Radiation Therapy
    Dholakia, A. S.
    Chaudhry, M.
    Leal, J. P.
    Raman, S. P.
    Hacker-Prietz, A.
    Wah, R. L.
    Laheru, D. A.
    Wolfgang, C. L.
    Herman, J. M.
    PANCREAS, 2013, 42 (08) : 1346 - 1346
  • [47] Pre-SBRT metabolic tumor volume and total lesion glycolysis to predict survival in patients with locally advanced pancreatic cancer receiving stereotactic body radiation therapy
    Dholakia, Avani Satish
    Chaudhry, Muhammad Ali
    Leal, Jeffrey P.
    Chang, Daniel Tandel
    Raman, Siva P.
    Su, Zheng
    Hacker-Prietz, Amy
    Pai, Jonathan
    Griffith, Mary E.
    Wahl, Richard L.
    Tryggestad, Erik
    Pawlik, Timothy M.
    Laheru, Daniel A.
    Wolfgang, Christopher Lee
    Koong, Albert
    Herman, Joseph M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [48] Stereotactic body radiation therapy planning with duodenal sparing using Volumetric-modulated arc therapy vs intensity-modulated radiation therapy in locally advanced pancreatic cancer: A dosimetric analysis
    Kumar, Rachit
    Wild, Aaron T.
    Ziegler, Mark A.
    Hooker, Ted K.
    Dah, Samson D.
    Tran, Phuoc T.
    Kang, Jun
    Smith, Koren
    Zeng, Jing
    Pawlik, Timothy M.
    Tryggestad, Erik
    Ford, Eric
    Herman, Joseph M.
    MEDICAL DOSIMETRY, 2013, 38 (03) : 243 - 250
  • [49] Bone-marrow Sparing Intensity-modulated Radiation Therapy (BMS-IMRT) for the Treatment of Early and Locally Advanced Carcinoma of the Anal Canal: Planning Procedure and Early Clinical Experience
    Vieillot, S.
    Fenoglietto, P.
    Lemanski, C.
    Moscardo, C. Llacer
    Menkarios, C.
    Gourgou, S.
    Dubois, J.
    Azria, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S282 - S283
  • [50] Treatment with pembrolizumab in combination with the oncolytic virus pelareorep promotes anti-tumor immunity in patients with advanced pancreatic adenocarcinoma.
    Mahalingam, Devalingam
    Chen, Siqi
    Xie, Ping
    Kalyan, Aparna
    Kircher, Sheetal Mehta
    Kocherginsky, Masha
    Xu, Jiahui
    Maurer, Victoria
    de Viveiros, Pedro Antonio Hermida
    Vagia, Elena
    Wilkinson, Grey A.
    Coffey, Matthew C.
    Mulcahy, Mary Frances
    Benson, Al Bowen
    Zhang, Bin
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)